Chargement

Slzii.com Recherche

Recherche (Nouvelles)

Aisa Pharma Announces Encouraging Results From Phase 2 RECONNOITER Trial Of AISA-021 (Cilnidipine) In Patients With Systemic Sclerosis-Associated Raynaud's Phenomenon

health top

(MENAFN - PR Newswire) AISA-021 demonstrated a significant improvement in the number of attack-free days and a reduction in median weekly Raynaud's attack frequency AISA-021 significantly ...
2026-03-06 08:01:57

Que fais-tu?
0.087994813919067


Nouvelles
Nouvelles

Dernières nouvelles et titres
(MENAFN - PR Newswire) AISA-021 demonstrated a significant improvement in the number of attack-free days and a reduction in median weekly Ra...
Nouvelles